当前位置:
X-MOL 学术
›
Clin. Chem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?
Clinical Chemistry ( IF 9.3 ) Pub Date : 2022-07-03 , DOI: 10.1093/clinchem/hvac085 Kahina Saker 1 , Bruno Pozzetto 2, 3 , Antonin Bal 1 , Martine Valette 1 , Jean Baptiste Fassier 4 , Carla Saade 1, 2 , Mary Anne Trabaud 1 , Sophie Trouillet-Assant 1, 2 ,
中文翻译:
在 Omicron 时代,抗受体结合域抗体仍然是监测 SARS-CoV-2 中和活性的相关代理吗?
更新日期:2022-05-26
Clinical Chemistry ( IF 9.3 ) Pub Date : 2022-07-03 , DOI: 10.1093/clinchem/hvac085 Kahina Saker 1 , Bruno Pozzetto 2, 3 , Antonin Bal 1 , Martine Valette 1 , Jean Baptiste Fassier 4 , Carla Saade 1, 2 , Mary Anne Trabaud 1 , Sophie Trouillet-Assant 1, 2 ,
Affiliation
中文翻译:
在 Omicron 时代,抗受体结合域抗体仍然是监测 SARS-CoV-2 中和活性的相关代理吗?